ArticleJournal of the ASEAN Federation of Endocrine Societies2026
Evaluating the Two-Step TSH Screening Protocol for Congenital Hypothyroidism: Prevalence and Diagnostic Accuracy in Ninh Binh, Vietnam.
Article in Journal of the ASEAN Federation of Endocrine Societies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to determine the prevalence of congenital hypothyroidism (CH) among newborns in Ninh Binh Province, Vietnam, and to evaluate whether adding a second thyroid-stimulating hormone (TSH) screening reduces false positives and improves diagnostic accuracy compared with the traditional single-step screening commonly practiced in Vietnam. Methodology: A retrospective cohort study was conducted on 11,306 newborns screened between January 2019 and December 2020. TSH levels were measured from dried blood spot samples, with a threshold of >9 mU/L indicating high risk. High-risk cases underwent a second screening, followed by confirmation with serum TSH and free thyroxine. Screening performance (sensitivity, specificity, positive predictive value [PPV], negative predictive value [NPV]) and risk factors for CH were analyzed. Results: The prevalence of high-risk CH was 2.40% (271/11,306 newborns), with four confirmed cases (incidence: 1:2,826). The two-step screening program achieved a sensitivity of 75.00%, with one false-negative case later detected clinically. Specificity improved from 97.64% in the first screening to 99.81% in the second, while PPV increased more than tenfold (1.11% → 11.54%). Low birth weight infants (≤2,500 g) had a significantly higher CH risk (OR: 10.04, 95% CI: 1.053-95.820, Conclusions: This first provincial evaluation of two-step CH screening in Vietnam demonstrated that repeat testing significantly reduced false positives and improved diagnostic accuracy without compromising sensitivity. The findings highlight the value of implementing a two-step strategy to optimize newborn screening, reduce unnecessary referrals and save resources in developing countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.